AST 2013 - Cutting Edge of Transplantation

Feb 14, 2013 ‐ Feb 16, 2013


A lack of understanding and failure to control antibodies is still a major barrier to transplantation and remains front and center in mechanisms of acute and chronic graft loss.

This meeting will bring together the experts to tackle these challenges to transplantation. Diagnostic experts will talk about the latest in crossmatching and detection of antibodies before, during and after transplantation. Top clinical investigators will review their experience with early and late allo-antibodies, desensitization practices, and their approaches using IVIG, bortizimib and anti-C5 complement antibodies. Leading basic scientists will discuss what regulates antibodies and antibody injury - including plasma cell development and B regulatory cells, and regulation by other antibodies. Advancing our mechanistic understanding of what produces and maintains sensitization is the only way to evolve our current approaches to eliminate anti-donor antibodies and manage resistance to therapy.

Standard: $99.00

Sessions

History of Antibodies in Transplantation

Feb 14, 2013 5:00pm ‐ Feb 14, 2013 5:20pm

Identification: TH01

Speaker(s):

The Clinical Challenge: The Sensitized Patient

Feb 14, 2013 5:20pm ‐ Feb 14, 2013 5:40pm

Identification: TH02

Speaker(s):

Trying to Treat the Known Unknown

Feb 14, 2013 5:40pm ‐ Feb 14, 2013 6:00pm

Identification: TH03

Much remains to be learned regarding anti-HLA antibodies in transplantation. A few of the examples where additional knowledge is needed include: 1) Factors that influence the marked variations in clinical phenotypes exhibited by antibody-mediated processes, 2) Processes that determine whether cellular or humoral mechanisms (or both) predominate in the alloresponse to human allografts, 3) Factors that influence antibody production, and responses to antihumoral therapies, 4) the extent to which antibody elimination is needed to achieve optimal results with antihumoral therapies.

What You'll Take Away from His Talk:

  • Accumulation of knowledge regarding anti HLA alloantibodies in transplantation is proceeding at a fast pace.
  • Requisite basic science in mice and humans is substantial but a broader and deeper understanding is needed.

Speaker(s):

Window into Basic Research: Clinical to Translational

Feb 14, 2013 6:00pm ‐ Feb 14, 2013 6:30pm

Identification: TH04

New approaches for characterizing HLA antibodies are transforming organ allocation and impacting clinical practice. Recent accomplishments, current controversies and opportunities to advance the field will be discussed.

What You'll Take Away from Her Talk

  • Improvements in histocompatibility testing have dramatically improved the efficiency of allocating organs from deceased donors and benefited highly sensitized patients.
  • Many factors that are not routinely measured are likely contribute to the effect of HLA antibodies in transplantation.

Speaker(s):

B Cell Biology: Cytokines, Development, and Maturation "101"

Feb 15, 2013 8:00am ‐ Feb 15, 2013 8:30am

Identification: FR01

B cells and plasma cells mediate functions critical to transplant success, including antibody production and antigen presentation, as well as positive and negative immunoregulatory activities. Understanding how the size and composition of pre-immune and antigen-experienced B cell niches are regulated should enable targeted prophylactic and therapeutic interventions. This presentation will overview current thought about the establishment and regulation of these different niches, highlighting emerging ideas relevant to their clinical manipulation.

What You'll Take Away from His Talk:

  • Pre-immune and antigen experienced B cell subsets occupy independent homeostatic niches.
  • Selection and survival in each niche is mediated by different key molecular families and signaling systems. These include the B cell antigen receptor complex, BLyS (BAFF) family members, and other positive and negative regulators.
  • Targeting appropriate members of these molecular families may allow the selective manipulation of B cell subsets to clinical advantage.

Speaker(s):

Understanding Human Autoreactive B Cells and Checkpoints

Feb 15, 2013 8:30am ‐ Feb 15, 2013 9:00am

Identification: FR02

Speaker(s):

B Regulatory CellsB Regulatory Cells

Preview Available

B Regulatory Cells

Feb 15, 2013 9:00am ‐ Feb 15, 2013 9:30am

Identification: FR03

  • Can Bregs be identified and induced to promote allograft tolerance and does TIM-1 play a functional role?
  • Can Bregs be separated from proinflammatory B cells subsets with opposing activity?
  • How do Bregs and proinflammatory B cells correlate with renal allograft function in humans?

Speaker(s):

Non-classical Roles of B CellsNon-classical Roles of B Cells

Preview Available

Non-classical Roles of B Cells

Feb 15, 2013 9:30am ‐ Feb 15, 2013 10:00am

Identification: FR04

The major question that I will address in my talk is how B cells regulate CD4 and CD8 T cell responses. We will show that B cells regulate T cell responses by both antibody dependent and independent mechanisms and therefore are important modulators of cellular immunity in the context of infection, autoimmunity and transplantation.

What You'll Take Away from Her Talk:

  • B cells regulate primary and memory CD4 and CD8 T cell responses via antibody independent mechanisms.
  • Antibody and antibody immune complexes can regulate DC-mediated development of CD8 memory responses to some, but not all, antigens.

Speaker(s):

Morphological and Molecular Correlates of Active Antibody-mediated Injury

Feb 15, 2013 10:30am ‐ Feb 15, 2013 11:00am

Identification: FR05

Speaker(s):

Intragraft B Cells: What Are They Doing?

Feb 15, 2013 11:00am ‐ Feb 15, 2013 11:30am

Identification: FR06

Speaker(s):
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content